Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? by Sunita M C De Sousa

Get full text

Serum prolactin overestimation and risk of misdiagnosis by Sunita M.C. De Sousa, Mohamed Saleem, Wayne Rankin, David J. Torpy

Get full text

Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities by Yang Timothy Du, Lynette Moore, Nicola K Poplawski, Sunita M C De Sousa

Get full text

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma by Annabelle G Hayes, Masoumeh G Shirazi, Anand Thiyagarajah, David J Torpy, Sunita M C De Sousa

Get full text

A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing’s disease by Sunita M. C. De Sousa, Jim Manavis, Jinghua Feng, Paul Wang, Andreas W. Schreiber, Hamish S. Scott, David J. Torpy

Get full text

PAM variants in patients with thyrotrophinomas, cyclical Cushing’s disease and prolactinomas by Sunita M. C. De Sousa, Sunita M. C. De Sousa, Sunita M. C. De Sousa, Angeline Shen, Angeline Shen, Christopher J. Yates, Christopher J. Yates, Roderick Clifton-Bligh, Roderick Clifton-Bligh, Roderick Clifton-Bligh, Stephen Santoreneos, James King, John Toubia, Giampaolo Trivellin, Giampaolo Trivellin, Andrea G. Lania, Andrea G. Lania, Constantine A. Stratakis, Constantine A. Stratakis, Constantine A. Stratakis, David J. Torpy, David J. Torpy, Hamish S. Scott, Hamish S. Scott

Get full text